| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 12.79 | 0.49 | 0.80 | 0.25 |
| Receivables | 24.79 | 32.77 | 13.10 | 20.27 |
| Inventory | 3.90 | 5.49 | 1.54 | — |
| Other | 116.69 | 123.18 | 46.68 | 40.53 |
| 158.17 | 161.93 | 93.13 | 77.15 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1.11 | 0.07 | 0.02 | 0.47 |
| ST’ Debt | 3.09 | 0.20 | — | — |
| Other | 0.63 | 0.64 | 2.10 | 3.10 |
| 10.71 | 10.06 | 9.96 | 13.67 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
27.97
|
| ’24 | — | — | — | — |
64.13
|
| ’23 | — | — | — | — |
110.36
|
| ’22 | 42.14 | — | 57.08 | — |
99.21
|
| ’21 | 17.79 | — | 21.50 | — |
39.29
|
| ’20 | 13.58 | — | 16.59 | — |
28.36
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.28) | — | — | — |
—
|
| ’25 | 14.57 | — | 52.46 | — |
52.46
|
| ’24 | (14.90) | — | (16.78) | — |
(16.78)
|
| ’23 | (11.30) | — | (75.75) | — |
(75.75)
|
| ’22 | 6.37 | — | 20.64 | — |
20.64
|
| ’21 | 9.73 | — | (52.91) | — |
(52.91)
|
| ’20 | 5.69 | — | (1.62) | — |
(1.62)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.70) | — | — | — |
—
|
| ’25 | 14.55 | — | 52.45 | — |
52.45
|
| ’24 | (14.90) | — | (16.81) | — |
(16.80)
|
| ’23 | (11.30) | — | (75.75) | — |
(75.75)
|
| ’22 | 6.37 | — | 20.63 | — |
20.63
|
| ’21 | 9.71 | — | (52.91) | — |
(52.91)
|
| ’20 | 5.52 | — | (1.78) | — |
(1.86)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
(28.92)
|
| ’24 | — | — | — | — |
(7.92)
|
| ’23 | — | — | — | — |
3.60
|
| ’22 | (0.65) | — | 0.12 | — |
9.60
|
| ’21 | 1.63 | — | 0.04 | — |
48.02
|
| ’20 | 0.00 | — | 1.37 | — |
120.05
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.44 | 12.48 | 2.04 | 1.26 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 696.00 | 110.40 | 28.20 | 7.08 | — | — | — |
High Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 56 | 70 | 42 | 15 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.77 | 1.58 | 1.53 | 1.86 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 99.21 | 110.36 | 64.13 | 27.97 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 5.48% | 3.88% | 6.04% | 2.87% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.11 | 2.86 | (4.63) | (53.39) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.12% | 2.59% | (7.22%) | (190.86%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.22 | 2.54 | (4.63) | (53.39) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.15 | 1.76 | 0.38 | 3.08 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 409.80 | 365.08 | 108.57 | 15.24 | — | — | — |
Revenue/Sh
|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.60 | 8.40 | (7.92) | (28.92) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 85.24 | (250.59) | (28.40) | 28.57 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.01) | 0.00 | (0.05) | (0.01) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 85.22 | (250.59) | (28.45) | 28.56 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 638.93 | 535.81 | 287.82 | 67.46 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.24 | 0.30 | 0.59 | 1.84 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.16 | 16.95 | 2.84 | 1.70 | — | — | — |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.28 | 3.33 | 0.56 | 0.33 | — | — | — |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.31 | 2.85 | 0.46 | 0.37 | — | — | — |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.74 | 3.28 | 0.57 | 0.34 | — | — | — |
EV/Sales
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (74.75) | (7.56) | (0.67) | 1.35 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.64 | (75.75) | (16.78) | 52.46 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | (0.03) | (0.02) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.63 | (75.75) | (16.80) | 52.45 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 144.97 | 147.46 | 151.87 | 83.17 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.80 | 4.74 | 2.38 | 1.81 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (74.52) | (8.05) | 1.89 | 1.01 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 154.68 | 161.98 | 170.02 | 123.86 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.35% | 1.50% | (2.57%) | (31.82%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.73% | 0.83% | 0.29% | (28.09%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.41% | 1.61% | (2.80%) | (36.14%) | — | — | — |
ROE
|
Farmmi, Inc. (FAMI), a NASDAQ-listed producer of premium organic mushrooms in China, exemplifies the volatility of microcap agribusiness stocks. After revenue surged from $20.7 million in 2016 to a peak of $110.4 million in 2023—driven by export demand and efficient scaling— the company now faces a stark reversal, with 2024 sales plunging 42% to $64.1 million and analysts forecasting a further 56% drop to $27.9 million in 2025. Gross margins have eroded from 17.6% in 2019 to a projected 2.9%, signaling lost pricing power amid competition, oversupply, and trade tensions, while net losses balloon to $53.4 million next year.
Despite operational woes, FAMI’s balance sheet offers some resilience, with shareholders’ equity at $170 million in 2024 (projected to dip to $123.9 million) and minimal debt, though heavy dilution has slashed book value per share 77% year-over-year. Trading at deeply discounted multiples—PS at 0.3x, PB near 0.5x—the stock appears cheap versus peers but screams value trap amid cash flow swings, regulatory hurdles, and insider silence. A potential FCF rebound in 2025 could stabilize it, but downside risks loom large without margin recovery or export relief—read the full analysis for the inflection points ahead.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.